6HCR image
Entry Detail
PDB ID:
6HCR
EMDB ID:
Title:
Synthetic Self-assembling ADDomer Platform for Highly Efficient Vaccination by Genetically-encoded Multi-epitope Display
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-08-16
Release Date:
2019-08-28
Method Details:
Experimental Method:
Resolution:
3.50 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Penton protein
Chain IDs:A (auth: z), B (auth: A), C (auth: B), D (auth: C), E (auth: D), F (auth: E), G (auth: F), H (auth: G), I (auth: H), J (auth: I), K (auth: J), L (auth: K), M (auth: L), N (auth: M), O (auth: N), P (auth: O), Q (auth: P), R (auth: Q), S (auth: R), T (auth: S), U (auth: T), V, W, X, Y, Z, AA (auth: a), BA (auth: b), CA (auth: c), DA (auth: d), EA (auth: e), FA (auth: f), GA (auth: g), HA (auth: h), IA (auth: i), JA (auth: j), KA (auth: k), LA (auth: l), MA (auth: m), NA (auth: n), OA (auth: o), PA (auth: p), QA (auth: q), RA (auth: r), SA (auth: s), TA (auth: t), UA (auth: u), VA (auth: v), WA (auth: w), XA (auth: x), YA (auth: y), ZA (auth: 1), AB (auth: 2), BB (auth: 3), CB (auth: 4), DB (auth: 5), EB (auth: 6), FB (auth: 7), GB (auth: 8), HB (auth: 9)
Chain Length:559
Number of Molecules:60
Biological Source:Human adenovirus B serotype 3
Ligand Molecules
Primary Citation
Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display.
Sci Adv 5 eaaw2853 eaaw2853 (2019)
PMID: 31620562 DOI: 10.1126/sciadv.aaw2853

Abstact

Self-assembling virus-like particles represent highly attractive tools for developing next-generation vaccines and protein therapeutics. We created ADDomer, an adenovirus-derived multimeric protein-based self-assembling nanoparticle scaffold engineered to facilitate plug-and-play display of multiple immunogenic epitopes from pathogens. We used cryo-electron microscopy at near-atomic resolution and implemented novel, cost-effective, high-performance cloud computing to reveal architectural features in unprecedented detail. We analyzed ADDomer interaction with components of the immune system and developed a promising first-in-kind ADDomer-based vaccine candidate to combat emerging Chikungunya infectious disease, exemplifying the potential of our approach.

Legend

Protein

Chemical

Disease

Primary Citation of related structures